Personalizing therapy for ovarian cancer: BRCAness and beyond.
Bast
Robert C
RC
Mills
Gordon B
GB
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D016190:Carboplatin / Q000627:therapeutic use; D005260:Female; D020869:Gene Expression Profiling; D019398:Genes, BRCA1; D024522:Genes, BRCA2; D006801:Humans; D009154:Mutation; D010051:Ovarian Neoplasms / Q000188:drug therapy* / Q000235:genetics; D011065:Poly(ADP-ribose) Polymerases / Q000627:therapeutic use; D057285:Precision Medicine / Q000379:methods*
D000970:Antineoplastic Agents; D016190:Carboplatin; D011065:Poly(ADP-ribose) Polymerases